Omron to acquire Luscii Healthtech

Omron Healthcare Co., Ltd. announced the acquisition of Luscii Healthtech. Since Omron’s seed investment in 2018, the two companies have collaborated closely, sharing knowledge and experience in the development of digital health. As a digital-native company and pioneer in smart remote care and virtual wards, Luscii cultivates a unique culture for innovation and agile philosophy allowing them successfully to address the complex and rapidly changing demands of healthcare systems.

Luscii provides a fully customizable platform and app for care at home, catering to over 150 diseases, including those affecting chronic hypertensive, cardiovascular, and respiratory patients. As the market leader in the Netherlands, where Luscii collaborates with approximately 70% of the country’s hospitals, the platform also extends its presence to other markets, including the UK, Germany and various other countries in Europe and Africa. Luscii’s integrated care network approach seamlessly connects various healthcare stakeholders, including general practitioners (GPs), hospitals, and community care and virtual ward call centers.

Through this interconnected system, Luscii achieves remarkable outcomes, including an 81% reduction in unplanned admissions for heart failure patients (*1), a 79% reduction in ultrasound examinations and admissions for gestational hypertension patients (*2), and a 51% reduction of costs in patients with COPD (*3). By leveraging data and fostering collaboration, healthcare providers are empowered to monitor and guide patients remotely, saving them time while ensuring better engagement and improved health outcomes.

Omron’s insight into the primary care remote patient-monitoring market in the UK and Europe will enable Luscii to develop comprehensive services to support healthcare professionals in an integrated way, ranging from general practitioners to hospitals, within a single platform. These solutions are designed to address a spectrum of diseases, aligning with Omron’s overarching “Going for Zero” vision, to eliminate heart attacks and strokes. This acquisition aims to elevate the standard of remote patient monitoring (RPM) services, contributing to a future where the impact of various diseases is minimized.

“Omron Healthcare is committed to developing life-saving cardiovascular health technologies in pursuit of our Going for Zero vision. As part of our long-term vision, we commit to expanding the business to digital health services, this acquisition is another significant contribution to that objective, and we will continue to advance digital healthcare and work together to save lives,” says Andre van Gils, Senior General Manager, Global Sales & Marketing HQ of Omron Healthcare.

“Luscii’s Vision, ‘creating space for care,’ aligns seamlessly with Omron’s objectives. It’s been our dream for every patient to get the attention they deserve,” says Prof. Daan Dohmen, CEO and founder of Luscii. “Benefiting from Omron’s global network, we can expand faster and realize our ambition even faster. Both my co-founders and all other team members are really looking forward to this next step in our mission!”
MB Bureau